Asian Spectator

The Times Real Estate

.

First Patient Enrolled in SELUTION SLR IDE BTK Study

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
LEIPZIG, Germany, June 8, 2022 /PRNewswire-AsiaNet/ -- The first patient has been enrolled in the FDA IDE BTK (Below-the-Knee) SELUTION4BTK clinical trial involving SELUTION SLR(TM), MedAlliance's novel sirolimus-eluting balloon, just one week after receiving IDE approval."I am excited to ...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Expert Legal Help | Personal Injury Lawyer in Brisbane

Suffering a personal injury can be a traumatic and life-changing experience, leaving you wondering what to do next. Navigating the complex world of personal injury law in Brisbane can be overwhelmin...

#IndonesiaGelap: Alarm bagi publik agar tak terlena narasi penguasa

Mahasiswa dari berbagai kampus berpartisipasi dalam aksi Indonesia Gelap di Jakarta untuk memprotes kebijakan pemerintah.@jackjackparrrBermula dari media sosial, tagar #IndonesiaGelap menjadi bentuk a...

Ketika pemberitaan penuh tekanan, bagaimana cara tetap ‘update’ tanpa ‘doomscrolling’?

Mart Production/PexelsAwalnya sesederhana kita mengintip media sosial favorit di tengah malam sebelum tidur. Lalu muncullah judul-judul berita yang menarik perhatian dengan keterangan “breaking ...